DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologicallyAshley R Tetens, Michael A. Koldobskiy, Allison Martin et al.|Neuro-Oncology Advances|2024Cited by 6
ATRT-12. HYPERACTIVATING THE INTEGRATED STRESS RESPONSE WITH PROTEASOME INHIBITION IN AT/RTOrlandi Novak, Eric H. Raabe, Tyler Findlay et al.|Neuro-Oncology|2023Cited by 1
Abstract 6720: Using proteasome inhibition to hyperactivate the integrated stress response in aggressive pediatric brain tumorsOrlandi Novak, Eric H. Raabe, Tyler Findlay et al.|Cancer Research|2023Cited by 0
DIPG-71. SELECTIVE HDAC INHIBITOR RG2833 INDUCES DIPG CELL DEATH VIA DOWNREGULATION OF THE NFĸB PATHWAYKatherine Barnett, Eric H. Raabe, Orlandi Novak et al.|Neuro-Oncology|2020Cited by 0
DIPG-42. MAPPING THE DNA METHYLATION LANDSCAPE OF DIPG REVEALS NOTABLE METHYLOME VARIABILITY RESPONSIVE TO PHARMACOLOGIC MODULATIONAshley R Tetens, Michael A. Koldobskiy, Allison Martin et al.|Neuro-Oncology|2023Cited by 0